Probiotics for ALS and related disorders
Part of Brain & nervous system, Hormones & metabolism clinical trials.
This trial tests whether probiotics (healthy bacteria) can help people with ALS. You'll take a probiotic or placebo daily for several months, and researchers will track your symptoms and gut health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18 or older
- Diagnosis of ALS (any type)
- ALS symptoms started within the last 2 years
- Able to walk, talk, and use your arms well enough (score of 24 or more on a standard test)
- Have a caregiver or family member who can help answer questions about your thinking and behavior
- Willing to avoid probiotics and antibiotics during the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medicine, CB03-154, to see if it can help people with ALS. Researchers are comparing different doses to find the safest and most effective one.
This trial tests if tofersen, a drug that targets a protein linked to ALS, can help people who have ALS but do not have mutations in the SOD1 or FUS genes. It aims to slow disease progression in those diagnosed within the last 2 years.
This trial tests whether a transplant of healthy gut bacteria (called a microbiome transplant) can slow down ALS in people whose disease is progressing rapidly. It aims to see if changing the gut environment can help with symptoms and quality of life.
This study looks at the bacteria in your gut (microbiome) to see if they are linked to different symptoms or types of ALS. It may help doctors understand more about the disease and could lead to better treatments in the future.
This trial tests whether FB1006 is safe and works better than usual care for treating amyotrophic lateral sclerosis (ALS). It focuses on people with relatively early ALS and good breathing function.
This study looks at complex brain and body changes in people with ALS and frontotemporal dementia (FTD), or related disorders. If you have one of these diagnoses—or a known gene mutation that can cause ALS/FTD—you may be able to help researchers learn how the conditions progress.
Hear when a new ALSFTD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.